Marti Deuter
- Democratic
- Representative
- District 45
Primary
Amends the Illinois Controlled Substances Act. Provides that the law concerning limitations on the over-the-counter sale of ephedrine without a prescription does not apply to the sale of any product dispensed or delivered by a practitioner or pharmacy according to a prescription issued by a prescriber authorized by the State or another state for a valid medical purpose and in the course of professional practice.
Public Act . . . . . . . . . 104-0252
Effective Date January 1, 2026
Governor Approved
Sent to the Governor
Added as Alternate Co-Sponsor Sen. Mary Edly-Allen
Passed Both Houses
Third Reading - Passed; 058-000-000
Placed on Calendar Order of 3rd Reading **
Placed on Calendar Order of 3rd Reading May 6, 2025
Second Reading
Do Pass Public Health; 007-000-000
Placed on Calendar Order of 2nd Reading May 1, 2025
Assigned to Public Health
First Reading
Referred to Assignments
Chief Senate Sponsor Sen. Laura Ellman
Arrive in Senate
Placed on Calendar Order of First Reading
Added Co-Sponsor Rep. Hoan Huynh
Third Reading - Short Debate - Passed 116-000-000
Added Chief Co-Sponsor Rep. Paul Jacobs
Added Chief Co-Sponsor Rep. William E Hauter
Added Chief Co-Sponsor Rep. Bob Morgan
Added Co-Sponsor Rep. Terra Costa Howard
Added Co-Sponsor Rep. Rick Ryan
Added Co-Sponsor Rep. Nicolle Grasse
Added Chief Co-Sponsor Rep. Theresa Mah
Placed on Calendar Order of 3rd Reading - Short Debate
Second Reading - Short Debate
Do Pass / Short Debate Health Care Licenses Committee; 014-000-000
Placed on Calendar 2nd Reading - Short Debate
Assigned to Health Care Licenses Committee
First Reading
Referred to Rules Committee
Filed with the Clerk by Rep. Martha Deuter
| Bill Text Versions | Format |
|---|---|
| Introduced | HTML PDF |
| Engrossed | HTML PDF |
| Enrolled | HTML PDF |
| Document | Format |
|---|---|
| Public Act |
Data on Open States is updated periodically throughout the day from the official website of the Illinois General Assembly.
If you notice any inconsistencies with these official sources, feel free to file an issue.